![Syndromes / Eculizumab / Hemolytic-uremic syndrome / Thrombocytopenia / Nephrology / Renal function / Meningococcal disease / Medicine / Health / Immunosuppressants Syndromes / Eculizumab / Hemolytic-uremic syndrome / Thrombocytopenia / Nephrology / Renal function / Meningococcal disease / Medicine / Health / Immunosuppressants](https://www.pdfsearch.io/img/b1452df0c18fe10e96b1ddebab89cdd0.jpg) Date: 2015-03-19 14:38:28Syndromes Eculizumab Hemolytic-uremic syndrome Thrombocytopenia Nephrology Renal function Meningococcal disease Medicine Health Immunosuppressants | | 1 INTERIM FUNDING CRITERIA IN ONTARIO FOR SOLIRIS AHUS –CASE BY CASE BASIS Initiation Criteria A patient must meet all three of the following to obtain funding for initial treatment of eculizumab for aHUS: 1. ConfirmedAdd to Reading ListSource URL: www.ahuscanada.orgDownload Document from Source Website File Size: 295,81 KBShare Document on Facebook
|